CAMX Stock Price, News & Analysis

robot
Abstract generation in progress

Camurus AB (CAMX) is a biopharmaceutical company specializing in long-acting medicines using its proprietary FluidCrystal® technology for severe and chronic diseases like opioid dependence, acromegaly, and polycystic liver disease. The article details its key products Buvidal/Brixadi and CAM2029 (Oczyesa/Oclaiz), clinical development, and collaborations with partners like Eli Lilly. It also provides stock information, news updates, financial highlights, and upcoming regulatory events for CAMX.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin